The Valley Desk

NCT06690775 · Interventional trial

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Overall registry status Active not recruiting

Phase 2

Conditions Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov